Neurogene (NGNE) Change in Cash (2013 - 2026)

Neurogene (NGNE) has 14 years of Change in Cash data on file, last reported at $20.3 million in Q1 2026.

• Quarterly Change in Cash rose 130.87% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.4 million (up 167.27% YoY) and the FY2025 annual result came in at -$32.7 million, down 177.63% from the prior year.
• Change in Cash slipped to $20.3 million in Q1 2026, from $32.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $113.6 million in Q4 2022 to a low of -$65.8 million in Q1 2025.
• A 5-year average of $3.2 million and a median of -$12.0 million in 2025 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash surged 1012.01% — and 2025, when it plunged 3837.37%.
• Tracing NGNE's Change in Cash over 5 years: stood at $113.6 million in 2022, then fell by 9.2% to $103.2 million in 2023, then plunged by 32.19% to $70.0 million in 2024, then sank by 53.05% to $32.8 million in 2025, then slumped by 38.14% to $20.3 million in 2026.
• The last three Change in Cash figures came in at $20.3 million (Q1 2026), $32.8 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.